Magnetic Resonance Imaging Pilot Study of Intravenous Glyburide in Traumatic Brain Injury.


Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
01 01 2020
Historique:
pubmed: 30 7 2019
medline: 13 4 2021
entrez: 30 7 2019
Statut: ppublish

Résumé

Pre-clinical studies of traumatic brain injury (TBI) show that glyburide reduces edema and hemorrhagic progression of contusions. We conducted a small Phase II, three-institution, randomized placebo-controlled trial of subjects with TBI to assess the safety and efficacy of intravenous (IV) glyburide. Twenty-eight subjects were randomized and underwent a 72-h infusion of IV glyburide or placebo, beginning within 10 h of trauma. Of the 28 subjects, 25 had Glasgow Coma Scale (GCS) scores of 6-10, and 14 had contusions. There were no differences in adverse events (AEs) or severe adverse events (ASEs) between groups. The magnetic resonance imaging (MRI) percent change at 72-168 h from screening/baseline was compared between the glyburide and placebo groups. Analysis of contusions (7 per group) showed that lesion volumes (hemorrhage plus edema) increased 1036% with placebo versus 136% with glyburide (

Identifiants

pubmed: 31354055
doi: 10.1089/neu.2019.6538
pmc: PMC6921286
doi:

Substances chimiques

Neuroprotective Agents 0
Glyburide SX6K58TVWC

Types de publication

Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

185-193

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL082517
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102589
Pays : United States

Références

Exp Neurol. 2012 May;235(1):282-96
pubmed: 22387180
Magn Reson Med. 2009 Sep;62(3):717-30
pubmed: 19623619
Neurocrit Care. 2017 Apr;26(2):213-224
pubmed: 27677908
MMWR Morb Mortal Wkly Rep. 2013 Jul 12;62(27):549-52
pubmed: 23842444
Biophys J. 1994 Jan;66(1):259-67
pubmed: 8130344
J Neurotrauma. 2017 Feb 15;34(4):925-933
pubmed: 27297934
Trends Pharmacol Sci. 2010 Dec;31(12):596-604
pubmed: 21035878
J Cereb Blood Flow Metab. 2013 Dec;33(12):1864-74
pubmed: 23942366
Neurocrit Care. 2014 Apr;20(2):319-33
pubmed: 24132564
J Neurosurg. 2018 Nov 1;129(5):1305-1316
pubmed: 29303442
Trauma Mon. 2016 Apr 24;21(5):e25113
pubmed: 28184360
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000
Crit Care. 2008;12(4):R98
pubmed: 18680584
Lancet Neurol. 2016 Oct;15(11):1160-9
pubmed: 27567243
J Neurotrauma. 2015 Aug 15;32(16):1246-53
pubmed: 25752340
Sci Transl Med. 2010 Apr 21;2(28):28ra29
pubmed: 20410530
Nat Med. 2006 Apr;12(4):433-40
pubmed: 16550187
Neuroscience. 2014 Jul 11;272:199-206
pubmed: 24792709
J Neurotrauma. 2019 Jun;36(11):1804-1817
pubmed: 30484364
Stroke. 2009 Mar;40(3 Suppl):S92-4
pubmed: 19064796
Crit Care Med. 2017 Mar;45(3):e255-e264
pubmed: 27845954
J Neurosurg. 1988 Jul;69(1):15-23
pubmed: 3288723
J Neurotrauma. 2015 Oct 1;32(19):1478-87
pubmed: 26398596
Stroke. 2014 Jan;45(1):281-3
pubmed: 24193798
Magn Reson Med. 2004 Sep;52(3):612-8
pubmed: 15334582
World Neurosurg. 2017 May;101:130-136
pubmed: 28185976
J Neurotrauma. 2009 Dec;26(12):2257-67
pubmed: 19604096
J Neurochem. 2015 Apr;133(1):144-52
pubmed: 25328080
J Mol Neurosci. 2008;34(1):51-61
pubmed: 18157658
Front Neurol. 2018 Jul 04;9:527
pubmed: 30022968
J Neurotrauma. 2019 Apr 1;36(7):1060-1079
pubmed: 30160201
Radiology. 1996 Dec;201(3):637-48
pubmed: 8939209
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1152-1162
pubmed: 29674479
J Clin Invest. 2007 Aug;117(8):2105-13
pubmed: 17657312
Eur J Neurosci. 2013 Dec;38(12):3786-98
pubmed: 24112298

Auteurs

Howard M Eisenberg (HM)

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland.

Martha E Shenton (ME)

Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Research and Development, VA Boston Healthcare System, Brockton Division, Brockton, Massachusetts.

Ofer Pasternak (O)

Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

J Marc Simard (JM)

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland.

David O Okonkwo (DO)

Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Christina Aldrich (C)

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland.

Feng He (F)

Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.

Sonia Jain (S)

Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.

Erik G Hayman (EG)

Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH